Search   
MSDS  : Imferon
CAS  : 9004-66-4
SYNONYMS  : * A 100 * A 100 (Pharmaceutical) * B 75 * Chinofer * Dextran iron complex * Dextrofer 75 * Eisendextran * Fe-Dextran * Fenate * Ferdex 100 * Ferric dextran * Ferridextran * Ferrodextran * Ferroglucin * Ferroglukin 75 * Imposil * Iro-Jex * Iron dextran * Iron-dextran complex * Iron dextran injection * Iron hydrogenated dextran * Ironorm injection * Myofer 100 * Polyfer * Prolongal * RCRA waste number U139 * Ursoferran
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : NI2200000
CHEMICAL NAME : Imferon
CAS REGISTRY NUMBER : 9004-66-4
OTHER CAS REGISTRY NOS. : 8050-93-9
53858-58-5
LAST UPDATED : 199806
DATA ITEMS CITED : 35
COMPOUND DESCRIPTOR : Tumorigen
Drug
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* A 100
* A 100 (Pharmaceutical)
* B 75
* Chinofer
* Dextran iron complex
* Dextrofer 75
* Eisendextran
* Fe-Dextran
* Fenate
* Ferdex 100
* Ferric dextran
* Ferridextran
* Ferrodextran
* Ferroglucin
* Ferroglukin 75
* Imposil
* Iro-Jex
* Iron dextran
* Iron-dextran complex
* Iron dextran injection
* Iron hydrogenated dextran
* Ironorm injection
* Myofer 100
* Polyfer
* Prolongal
* RCRA waste number U139
* Ursoferran

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3 gm(Fe)/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
18,185,1971

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1617 mg(Fe)/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ACVTA8 Acta Veterinaria (Belgrade). (Jugoslovenska Knjiga, POB 36,
YU-11001, Belgrade, Yugoslavia) V.1- 1951- Volume(issue)/page/year:
29,21,1979

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1 gm(Fe)/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK)
V.1-33, 1946-68. For publisher information, see BJPCBM.
Volume(issue)/page/year: 24,352,1965

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 460 mg(Fe)/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APPHAX Acta Poloniae Pharmaceutica. For English translation, see APPFAR.
(Ars Polona, POB 1001, 00-680 Warsaw 1, Poland) V.1- 1937-
Volume(issue)/page/year: 18,149,1961

TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >450 mg(Fe)/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK)
V.1-33, 1946-68. For publisher information, see BJPCBM.
Volume(issue)/page/year: 10,375,1955

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 500 mg(Fe)/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK)
V.1-33, 1946-68. For publisher information, see BJPCBM.
Volume(issue)/page/year: 10,375,1955

TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : >690 mg(Fe)/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK)
V.1-33, 1946-68. For publisher information, see BJPCBM.
Volume(issue)/page/year: 10,375,1955

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 700 mg/kg/7D-I
TOXIC EFFECTS :
Cardiac - other changes
Liver - other changes
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - other oxidoreductases
REFERENCE :
JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub.,
1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76-
Volume(issue)/page/year: 51,235,1997

** TUMORIGENIC DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 20 mg/kg/3Y-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
2,277,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 750 mg(Fe)/kg/4W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
IJCNAW International Journal of Cancer. (International Union Against
Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966-
Volume(issue)/page/year: 2,370,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1150 mg/kg/17W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills,
Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year:
15,838,1961

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2300 mg/kg/I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Blood - lymphoma, including Hodgkin's disease
Tumorigenic - tumors at site of application
REFERENCE :
BECCAN Annual Report--Cancer Research Campaign. (Cancer Research Campaign,
2 Carlton House Terrace, London SW1Y 5AR, UK) V.1- 1924-
Volume(issue)/page/year: 40,30,1962

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2 gm(Fe)/kg/9W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills,
Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year:
21,448,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 28 gm/kg/27W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
1,1593,1964

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - hamster
DOSE/DURATION : 40 gm/kg/10W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
24,109,1960

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1120 mg(Fe)/kg/28W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
1,1800,1962

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3760 mg(Fe)/kg/47W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
1,947,1959

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 104 gm/kg/26W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
24,109,1960

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1500 mg(Fe)/kg/8W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
IJCNAW International Journal of Cancer. (International Union Against
Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966-
Volume(issue)/page/year: 2,370,1967

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 52 mg(Fe)/kg/6W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
1,1411,1960

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2400 mg(Fe)/kg/24W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills,
Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year:
18,801,1964

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 104 gm/kg/13W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Lungs, Thorax, or Respiration - bronchiogenic carcinoma
Tumorigenic - tumors at site of application
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
24,109,1960

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE : 2580 gm/kg
SEX/DURATION : female 17-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85,
Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 5,147,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE : 240 mg/kg
SEX/DURATION : female 6 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
Reproductive - Effects on Newborn - behavioral
REFERENCE :
BPNSBY Bulletin of the Psychonomic Society. (Psychonomic Soc., 2904
Guadalupe St., Austin, TX 78705) V.1- 1973- Volume(issue)/page/year:
10,49,1977

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intrauterine
SPECIES OBSERVED : Rodent - rat
DOSE : 52500 ug/kg
SEX/DURATION : female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - uterus, cervix, vagina
REFERENCE :
IJEBA6 Indian Journal of Experimental Biology. (Publications & Information
Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-
Volume(issue)/page/year: 19,1124,1981

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rabbit
DOSE : 650 mg(Fe)/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
SJHSBD Scandinavian Journal of Haematology, Supplementum. (Munksgaard
International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) No.1- 1967-
Volume(issue)/page/year: 32,69,1977

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intrauterine
SPECIES OBSERVED : Rodent - rat
DOSE : 5250 ug/kg
SEX/DURATION : female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - uterus, cervix, vagina
Reproductive - Fertility - female fertility index (e.g. # females pregnant
per # sperm positive females; # females pregnant per # females mated)
REFERENCE :
IJEBA6 Indian Journal of Experimental Biology. (Publications & Information
Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-
Volume(issue)/page/year: 19,1124,1981

*** REVIEWS ***

IARC Cancer Review:Animal Sufficient Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 2,161,1973

IARC Cancer Review:Human Inadequate Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 2,161,1973

IARC Cancer Review:Group 2B
IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49
Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year:
7,226,1987

TOXICOLOGY REVIEW
FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For
publisher information, see FCTOD7. Volume(issue)/page/year: 9,105,1971

TOXICOLOGY REVIEW
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
1,683,1978

TOXICOLOGY REVIEW
PEXTAR Progress in Experimental Tumor Research. (S. Karger AG, Postfach
CH-4009 Basel, Switzerland) V.1- 1960- Volume(issue)/page/year:
12,102,1969

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X4721
No. of Facilities: 39 (estimated)
No. of Industries: 1
No. of Occupations: 2
No. of Employees: 1157 (estimated)
No. of Female Employees: 573 (estimated)

*** STATUS IN U.S. ***

NTP 7th Annual Report on Carcinogens, 1992 : anticipated to be carcinogen


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Illicium anisatum L., leaf extractSUBSTANCE DEFINITION :Plant belonging to the family MagnoliaceaeREFERENCE :NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (NipponYakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho,Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- Volume(issue)/page/year:55,524,1959 93196-20-4
Hydrazine, (2-(m-methoxyphenoxy)ethyl)-, maleate 70145-85-6
Illicium anisatum L., root extractSUBSTANCE DEFINITION :Plant belonging to the family MagnoliaceaeREFERENCE :NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (NipponYakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho,Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- Volume(issue)/page/year:55,524,1959 70145-85-6
Illicium anisatum L., stem extractSUBSTANCE DEFINITION :Plant belonging to the family MagnoliaceaeREFERENCE :NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (NipponYakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho,Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- Volume(issue)/page/year:55,524,1959 70145-85-6
Illicium griffithii Hook.f. & Thoms., extractexcluding rootsSUBSTANCE DEFINITION :Plant belonging to the family MagnoliaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 26,883,1988 70145-85-6
Imanin 11113-64-7
Imbrimycin 57515-29-4
Imferon 9004-66-4
Imgreite 24270-51-7
3H-Imidazo(2,1-b)(3)benzazepine,2,5,6,11-tetrahydro-, sulfate (1:1) 121771-84-4
8,11-Iminoazepino(1,2-b)isoquinoline-10-carboxylicacid, 5,7,8,9,10,11,11a,12-octahydro-1-chloro-7-cyano-5-(hydroxymethyl)-4-methoxy-13-methyl- 118560-27-3
9H-Imidazo(1,2-a)benzimidazole,2-(p-bromophenyl)-9-(2-(diethylamino)ethyl)-,dihydrochloride 38652-51-6
Hydrazine, (1-(o-methoxyphenoxymethyl)ethyl)-,hydrochloride 70145-88-9
9H-Imidazo(1,2-a)benzimidazole,2-tert-butyl-9-(2-(diethylamino)ethyl)-,dihydrochloride 72025-08-2
9H-Imidazo(1,2-a)benzimidazole-3-carboxylic acid,9-butyl-2-((methyltricyclo(3.3.1.1(sup3,7))dec-1-ylamino)methyl)-, methyl ester,dihydrochloride 119294-99-4
9H-Imidazo(1,2-a)benzimidazole-3-carboxylic acid,9-(2-(diethylamino)ethyl)-2-methyl-, methyl ester,dihydrochloride 41472-74-6
9H-Imidazo(1,2-a)benzimidazole-3-carboxylic acid,9-methyl-2-((methyltricyclo (3.3.1.1(sup3,7))dec-1-ylamino)methyl)-, ethyl ester,dihydrobromide 119294-98-3
9H-Imidazo(1,2-a)benzimidazole-3-carboxylic acid,9-methyl-2-((methyltricyclo (3.3.1.1(sup3,7))dec-1-ylamino)methyl)-, methyl ester,dihydrochloride 119294-97-2
9H-Imidazo(1,2-a)benzimidazole,9-(2-(diethylamino)ethyl)-2-(p-methoxyphenyl)-,dihydrochloride 72025-06-0
9H-Imidazo(1,2-a)benzimidazole,9-(2-(diethylamino)ethyl)-3-(methylcarbonyl)-2-phenyl-, dihydrochloride 41472-76-8
9H-Imidazo(1,2-a)benzimidazole,9-(2-(diethylamino)ethyl)-2-methyl-, dihydrochloride 23572-37-4
9H-Imidazo(1,2-a)benzimidazole,9-(2-(diethylamino)ethyl)-2-(1-naphthyl)-,dihydrochloride 72025-04-8
9H-Imidazo(1,2-a)benzimidazole,9-((2-diethylamino)ethyl)-2-phenyl-, dihydrochloride 23572-32-9
Hydrazine, (1-(p-methoxyphenoxymethyl)ethyl)-,maleate 70145-87-8
9H-Imidazo(1,2-A)benzimidazole,9-(2-(diethylamino)ethyl)-2-phenyl-, dinitrate 72025-10-6
9H-Imidazo(1,2-a)benzimidazole,9-(2-(diethylamino)ethyl)-2-phenyl-, sulfate 72025-11-7
3H-Imidazo(1,2-a)benzimidazole, 2,9-dihydro-9-butyl-,monohydrochloride 111679-07-3
3H-Imidazo(1,2-a)benzimidazole,2,9-dihydro-9-ethyl-2-phenyl-, monohydrochloride 111679-15-3
3H-Imidazo(1,2-a)benzimidazole,2,9-dihydro-9-methyl-, monohydrochloride 109753-62-0
9H-Imidazo(1,2-a)benzimidazole,2,3-dihydro-1-methyl-2-phenyl-, dihydrochloride 109753-62-0
3H-Imidazo(1,2-a)benzimidazole,2,9-dihydro-9-(2-(1-piperidinyl)ethyl)-,dihydrochloride 111679-14-2
3H-Imidazo(1,2-a)benzimidazole,2,9-dihydro-9-propyl-, monohydrochloride 111679-06-2
9H-Imidazo(1,2-a)benzimidazole,9-((3-dimethylamino)propyl)-2-(p-bromophenyl)-,dihydrochloride 38652-53-8
9H-Imidazo(1,2-a)benzimidazole,9-((3-dimethylamino)propyl)-2-(p-chlorophenyl)-,dihydrochloride 38652-52-7
Hydrazine, (3-(p-methoxyphenyl)-1-methylpropyl)-,oxalate (1:1) 38652-52-7
9H-Imidazo(1,2-a)benzimidazole, 1-methyl-2-phenyl-,dihydrochloride 38652-52-7
9H-Imidazo(1,2-a)benzimidazole,2-phenyl-9-(2-piperidinoethyl)-, dihydrochloride 23572-35-2
5H-Imidazo(2,1-c)(1,4)benzodiazepine 78105-30-3
5H-Imidazo(2,1-c)(1,4)benzodiazepine,8-benzyloxy-7-methoxy- 98234-93-6
4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylicacid, 8-fluoro-5,6-dihydro-5-methyl-6- oxo-, ethylester 78755-81-4
5H-Imidazo(2,1-c)(1,4)benzodiazepine, 7-chloro- 98234-95-8
4H-Imidazo(1,5-a)(1,4)benzodiazepine,8-chloro-6-(2-fluorophenyl)-1-methyl- 59467-70-8
4H-Imidazo(1,5-a)(1,4)benzodiazepine,8-chloro-6-(2-fluorophenyl)-1-methyl-,(Z)-2-butenedioate (1:1) 59467-94-6
4H-Imidazo(1,5-a)(1,4)benzodiazepine,8-chloro-6-(2-fluorophenyl)-1-methyl-, hydrochloride 59467-96-8
5H-Imidazo(2,1-c)(1,4)benzodiazepine, 10,11-dihydro- 78105-31-4
Hydrazine, (2-(p-methoxyphenylthio)ethyl)-, maleate 70145-82-3
Imidazo(4,5,1-jk)(1,4)benzodiazepine,4,5-dihydro-9-chloro-7-ethoxy-2-methyl- 66596-66-5
Imidazo(4,5,1-jk)(1,4)benzodiazepine,4,5-dihydro-9-chloro-7-ethoxy-2-(phenylmethyl)- 66596-71-2
5H-Imidazo(2,1-c)(1,4-benzodiazepine,9,10-dihydro-7,8-dimethoxy- 98234-96-9
5H-Imidazo(2,1-c)(1,4)benzodiazepine, 7,8-dimethoxy- 98234-92-5

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net